Antti Ylitalo, MD, PhD

Original Contribution
Gender-Based Analysis of the 3-Year Outcome of Bioactive Stents Versus Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction: An Insight from the TITAX-AMI Trial
02/29/2012
Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...
Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...
Abstract: Background. The...
02/29/2012
Journal of Invasive Cardiology
Original Contribution
Early Vascular Healing After Endothelial Progenitor Cell Capturing Stent Implantation
11/29/2012
Abstract: Objectives. To assess early vascular healing with endothelial progenitor cell (EPC)-capturing stents. Background. Endothelialization of stent struts is crucial after stenting, since delayed vascular healing predisposes to stent...
Abstract: Objectives. To assess early vascular healing with endothelial progenitor cell (EPC)-capturing stents. Background. Endothelialization of stent struts is crucial after stenting, since delayed vascular healing predisposes to stent...
Abstract: Objectives. To assess...
11/29/2012
Journal of Invasive Cardiology
Original Contribution
Vascular Healing Early After Titanium-Nitride-Oxide-Coated Stent Implantation Assessed by Optical Coherence Tomography
04/01/2013
Prospective registry explores the extent of neointimal coverage of stent struts by optical coherence tomography at 30 days following the implantation of bioactive stents in an unselected non-diabetic population.
Prospective registry explores the extent of neointimal coverage of stent struts by optical coherence tomography at 30 days following the implantation of bioactive stents in an unselected non-diabetic population.
Prospective registry explores...
04/01/2013
Journal of Invasive Cardiology
Late Stent Thrombosis of a Second-Generation Drug-Eluting Stent
10/02/2012
ABSTRACT: A 62-year-old male patient presented with acute non-ST-elevation myocardial infarction. He underwent successful percutaneous coronary intervention with implantation of an everolimus-eluting stent in the left anterior descending...
ABSTRACT: A 62-year-old male patient presented with acute non-ST-elevation myocardial infarction. He underwent successful percutaneous coronary intervention with implantation of an everolimus-eluting stent in the left anterior descending...
ABSTRACT: A 62-year-old male...
10/02/2012
Journal of Invasive Cardiology
Original Contribution
Titanium and Nitride Oxide-Coated Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in an Unselected Populatio
08/01/2008
Coronary stents have reduced the risk of periprocedural complications and restenosis compared to balloon angioplasty alone.1,2 In spite of this progress, restenosis is still a clinical problem of bare metal stents, particularly in certain...
Coronary stents have reduced the risk of periprocedural complications and restenosis compared to balloon angioplasty alone.1,2 In spite of this progress, restenosis is still a clinical problem of bare metal stents, particularly in certain...
Coronary stents have reduced the...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Pooled Analysis of Trials Comparing Titanium-Nitride-Oxide-Coated Stents with Paclitaxel-Eluting Stents in Patients Undergoing
07/06/2010
   ABSTRACT: We performed a pooled analysis of three trials comparing titanium-nitride-oxide-coated bioactive stents (BAS) with paclitaxel-eluting stents (PES) in 1,774 patients. All patients were followed for 12 months. The primary outcomes...
   ABSTRACT: We performed a pooled analysis of three trials comparing titanium-nitride-oxide-coated bioactive stents (BAS) with paclitaxel-eluting stents (PES) in 1,774 patients. All patients were followed for 12 months. The primary outcomes...
   ABSTRACT: We performed a...
07/06/2010
Journal of Invasive Cardiology

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use